Cargando…

Ovarian Cancer Biomarkers in the COVID-19 Era

Ovarian Cancer (OC) diagnosis is entrusted to CA125 and HE4. Since the latter has been found increased in COVID-19 patients, in this study, we aimed to evaluate the influence of SARS-CoV-2 infection on OC biomarkers. HE4 values above the cut-off were observed in 65% of OC patients and in 48% of SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farina, Antonella, Colaiacovo, Flavia, Gianfrate, Mariacarmela, Pucci, Beatrice, Angeloni, Antonio, Anastasi, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252324/ https://www.ncbi.nlm.nih.gov/pubmed/37297598 http://dx.doi.org/10.3390/ijerph20115994

Ejemplares similares

Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
por: Anastasi, Emanuela, et al.
Publicado: (2023)

Anti-N SARS-CoV-2 assays for evaluation of natural viral infection
por: Gaeta, Aurelia, et al.
Publicado: (2023)

Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int. J. Environ. Res. Public Health 2021, 18, 3491
por: Ialongo, Cristiano, et al.
Publicado: (2021)

The Complementary Role of Imaging and Tumor Biomarkers in Gynecological Cancers: An Update of the Literature
por: Anastasi, Emanuela, et al.
Publicado: (2018)

PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma
por: Tartaglione, Sara, et al.
Publicado: (2021)

Is CA72-4 a Useful Biomarker in Differential Diagnosis between Ovarian Endometrioma and Epithelial Ovarian Cancer?
por: Anastasi, Emanuela, et al.
Publicado: (2013)

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients
por: Anastasi, Emanuela, et al.
Publicado: (2022)

Role of Galectin-3 Combined with Multi-Detector Contrast Enhanced Computed Tomography in Predicting Disease Recurrence in Patients with Ovarian Cancer
por: Anastasi, Emanuela, et al.
Publicado: (2017)

Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering
por: Farina, A., et al.
Publicado: (2021)

Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study
por: Tartaglione, Sara, et al.
Publicado: (2019)

Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
por: Anastasi, Emanuela, et al.
Publicado: (2023)

The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
por: Anastasi, Emanuela, et al.
Publicado: (2013)

Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
por: Robotti, Marzia, et al.
Publicado: (2023)

Social Frailty in the COVID-19 Pandemic Era
por: Lozupone, Madia, et al.
Publicado: (2020)

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab
por: Antonelli, Guido, et al.
Publicado: (2021)

Disposable Voltammetric Immunosensor for D-Dimer Detection as Early Biomarker of Thromboembolic Disease and of COVID-19 Prognosis
por: Tortolini, Cristina, et al.
Publicado: (2022)

Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine
por: Watanabe, Mikiko, et al.
Publicado: (2022)

New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric Study
por: Angeloni, Antonio, et al.
Publicado: (2022)

Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020)

Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era
por: Aleksova, Aneta, et al.
Publicado: (2021)

Quality of vision and outcomes after bilateral implantation of pseudo-non diffracting beam IOL
por: Pedrotti, Emilio, et al.
Publicado: (2023)

Association of serum Krebs von den Lungen-6 and chest CT as potential prognostic factors in severe acute respiratory syndrome SARS-CoV-2: a preliminary experience
por: Anastasi, Emanuela, et al.
Publicado: (2022)

Blood factors as biomarkers in osteoporosis: points from the COVID-19 era
por: Salamanna, Francesca, et al.
Publicado: (2021)

The mediating role of exogenous shocks in green purchase intention: evidence from italian fashion industry in the Covid-19 era
por: Annunziata, Eleonora, et al.
Publicado: (2023)

Neurofibromatosis: New Clinical Challenges in the Era of COVID-19
por: Ardizzone, Alessio, et al.
Publicado: (2022)

Thyroid cancer in the Era of COVID-19
por: Smulever, Anabella, et al.
Publicado: (2020)

Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination
por: Cangemi, Roberto, et al.
Publicado: (2022)

Disparity in the era of personalized medicine for epithelial ovarian cancer
por: Devlin, Michael-John, et al.
Publicado: (2023)

Successful IVC thrombus extraction with the AngioVac device following five vessel coronary artery bypass graft: a case report
por: Neubauer, Steven, et al.
Publicado: (2021)

Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era
por: Alexiou, George A, et al.
Publicado: (2021)

Telemonitoring in the Covid-19 Era: The Tuscany Region Experience
por: Panicacci, Silvia, et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
por: Capuano, Cristina, et al.
Publicado: (2023)

Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
por: Burgaletto, Chiara, et al.
Publicado: (2021)

Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
por: Mancini, Patrizia, et al.
Publicado: (2014)

Managing patients with cancer in the COVID-19 era
por: Peng, Ling, et al.
Publicado: (2020)

Colorectal cancer screening in the COVID-19 era
por: Kadakuntla, Anusri, et al.
Publicado: (2021)

Cancer diagnosis in Brazil in the COVID-19 era
por: Marques, Nelson Pereira, et al.
Publicado: (2021)

COVID-19 and blood cancer in the vaccination era
por: Hicks, Lisa K., et al.
Publicado: (2022)

Emerging Biomarkers in the Era of Personalized Cancer Medicine
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Colorectal Cancer Biomarkers in the Era of Personalized Medicine
por: Patel, Jai N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d08nmuosich4v2fhs4e7ennmee